Collecting Blood and Brain Tissue to Study Drug-Resistant Epilepsy
Collects blood and brain tissue from adults having surgery for drug-resistant focal epilepsy.
Plain-language title generated from the registry record
Registry title: Multimodal Study of the Human Brain Epilepsy Tissue
Key facts
- Where
- Paris, FranceSee the site
Where in France
- Department of Neurology, Epilepsy Unit, Pitié-Salpêtrière HospitalParis, FranceTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Assistance Publique - Hôpitaux de Paris
- Trial code
- NCT06022055
- Record updated
- 16 July 2026
- Original description
The TIPI2 study is a blood and tissue collection protocol to create an annotated biorepository to support research in drug-resistant epilepsy.Read full original descriptionShow less
Multimodal Study of the Human Brain Epilepsy Tissue
The TIPI2 study is a blood and tissue collection protocol to create an annotated biorepository to support research in drug-resistant epilepsy.
The aim of the study will be to identify new pathophysiological pathways. For this purpose, the investigators will investigate with a multimodal approach blood and brain samples from patients undergoing a surgery for focal drug-resistant epilepsy. The adult patients will be enrolled either during the pre-surgical evaluation or right before the surgery.
Inclusion: 18 yo or above; patients with a focal drug-resistant epilepsy; patients hospitalized for a pre-surgical evaluation or for an epilepsy surgery; consent obtained from the patient, or legally authorized representative; affiliated to a social security system.
Exclusion: None.